Sentinel Lymph Node clinical trials

Explore recruiting sentinel lymph node clinical trials.

Recruiting sentinel lymph node studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sentinel Lymph Node trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

VALIDATION OF THE SENTINEL LYMPH NODE TECHNIQUE IN EARLY-STAGE OVARIAN CANCER (SENTOV II)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

NeoMatryx - Neoadjuvant Merkel cell carcinoma therapy (Tx) with the PD-1 inhibitor Cemiplimab – A randomized, double-blind, placebo-controlled, non-comparative Phase II study

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Sentinel node detection with 99Tc albumin nanocolloid and indocianine green (ICG) in patients with epithelial ovarian cancer in early stages. Pilot study.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A feasibility study. (SNparotis)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Perioperative treatment with Tranexamic Acid (TXA) in melanoma; prognostic and treatment related impact of the plasminogen-plasmin pathway

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sentinel Lymph Node trials by city

Sentinel Lymph Node in Toronto Sentinel Lymph Node in Vancouver Sentinel Lymph Node in Montreal Sentinel Lymph Node in Calgary Sentinel Lymph Node in Edmonton Sentinel Lymph Node in Ottawa Sentinel Lymph Node in Winnipeg Sentinel Lymph Node in Quebec City Sentinel Lymph Node in Hamilton Sentinel Lymph Node in Kitchener Sentinel Lymph Node in London Sentinel Lymph Node in Halifax Sentinel Lymph Node in New York Sentinel Lymph Node in Los Angeles Sentinel Lymph Node in Chicago Sentinel Lymph Node in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease